Swiss CMDO Lonza said it will expand its Early Development Services (EDS) offering into North America with a new laboratory in Cambridge, Massachusetts, set to open in...
Successfully managing the drug substance manufacturing of Antibody-Drug Conjugates (ADCs) requires a sophisticated understanding of the technological development process...
05.04.2019
- Swiss fine chemicals producer Lonza and Danish biosciences company Chr. Hansen are forming a 50:50 joint venture to develop and manufacture live biotherapeutic products (LBPs) for...
02.09.2016
- During the last two decades the pharmaceutical industry was forced to undertake significant structural changes to address mounting challenges from strict regulatory policies, lower...
24.08.2016
- Swiss drugmaker Roche has agreed to pay a total of around $270 million to gain access to Eleven Biotherapeutics’ potential eye treatment EBI-031. A humanized monoclonal antibody...
14.01.2016
- US drug firm Pfizer is linking with non-profit organization The California Institute for Biomedical Research (Calibr) to develop new heart failure treatments. Calibr said its...
12.11.2012
- The Hamburg, Germany-based biotech startup GeneQuine Biotherapeutics today announced the completion of a seven-figure seed financing round. Investors are the German seed funds High...
